FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical stimulation for adults, available in 2026.

Add Yahoo as a preferred source to see more of our stories on Google. Chinese researchers have unveiled the world’s first battery-powered, wearable repetitive transcranial magnetic stimulation (rTMS) ...

Nexalin’s growing body of published data consistently demonstrates objective normalization of abnormal brain activity and ...

A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for treating attention-deficit/hyperactivity disorder, does not effectively ...

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...

Flow’s headset is the first tDCS device approved by the FDA ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms. The ...

A home-based brain stimulation device appeared to boost cognition in patients with early Alzheimer's disease (AD), although the effect was small, a new study showed. Patients who received active ...

NORTHVILLE, Mich., Oct. 1, 2025 /PRNewswire/ -- For individuals battling depression or anxiety there's hope from a breakthrough technology, now available at Northville Beauty Spa in Northville, ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies that ...